| Literature DB >> 36074797 |
Benjamin F Bigelow1, Ronald E Saxton, Diego A Martínez, Alejandra Flores-Miller, Jong M Shin, Cassandra Parent, Samantha Williams, Katherine Hartman Phillips, Cui Yang, Kathleen Raquel Page.
Abstract
BACKGROUND: Despite the disproportionate impact of COVID-19 on Latinos, there were disparities in vaccination, especially during the early phase of COVID-19 immunization rollout.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36074797 PMCID: PMC9528932 DOI: 10.1097/PHH.0000000000001625
Source DB: PubMed Journal: J Public Health Manag Pract ISSN: 1078-4659
Characteristics of N = 2250 Patients at Community Vaccination Events Tailored for Latinx Communities Occurring February 26 Through May 8, 2021
| Total | Total | Active Phone Outreach | Passive Outreach (Hotline Callers) | Street Outreach | Walk-ups | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n | % | 95% CI | n | % | 95% CI | n | % | 95% CI | n | % | 95% CI | n | % | 95% CI | |
| 2250 | 100.0% | ... | 588 | 100.0% | ... | 606 | 100.0% | ... | 335 | 100.0% | ... | 721 | 100.0% | ... | |
| Age | |||||||||||||||
| Age in years, mean (SD) | ... | 47.1 | (13.82) | ... | 54.6 | (11.51) | ... | 47.4 | (12.82) | ... | 41.9 | (12.28) | ... | 43.0 | (14.32) |
| <18 | 26 | 1.2% | 0.7%-1.6% | 0 | 0.0% | 0.0%-0.6% | 6 | 1.0% | 0.4%-2.1% | 3 | 0.9% | 0.3%-2.5% | 17 | 2.4% | 1.4%-3.7% |
| 18-29 | 187 | 8.3% | 7.2%-9.5% | 7 | 1.2% | 0.5%-2.4% | 33 | 5.4% | 3.9%-7.5% | 48 | 14.3% | 10.9%-18.4% | 99 | 13.7% | 11.4%-16.4% |
| 30-44 | 795 | 35.3% | 33.3%-37.3% | 97 | 16.5% | 13.7%-19.7% | 227 | 37.5% | 33.6%-41.3% | 157 | 46.9% | 41.5%-52.2% | 314 | 43.6% | 39.9%-47.1% |
| 45-64 | 1009 | 44.8% | 42.7%-46.9% | 373 | 63.4% | 59.4%-67.2% | 285 | 47.0% | 43.0%-51.0% | 113 | 33.7% | 28.8%-38.9% | 238 | 33.0% | 29.6%-36.5% |
| 65-74 | 175 | 7.8% | 6.7%-8.9% | 81 | 13.8% | 11.2%-16.7% | 41 | 6.8% | 5.0%-9.0% | 13 | 3.9% | 2.2%-6.5% | 40 | 5.5% | 4.1%-7.4% |
| >74 | 58 | 2.6% | 1.9%-3.3% | 30 | 5.1% | 3.5%-7.1% | 14 | 2.3% | 1.3%-3.8% | 1 | 0.3% | 0.05%-1.6% | 13 | 1.8% | 1.0%-3.0% |
| Gender | |||||||||||||||
| Female | 1134 | 50.4% | 48.3%-52.4% | 318 | 54.1% | 50%-58.0% | 312 | 51.5% | 47.5%-55.4% | 171 | 51.0% | 45.7%-56.3% | 333 | 46.2% | 42.5%-49.8% |
| Male | 1116 | 49.6% | 47.5%-51.6% | 270 | 45.9% | 41.9%-49.9% | 294 | 48.5% | 44.5%-52.4% | 164 | 49.0% | 43.6%-54.2% | 388 | 53.8% | 50.1%-57.4% |
| Race | |||||||||||||||
| White | 119 | 5.3% | 4.4%-6.2% | 26 | 4.4% | 3.0%-6.4% | 24 | 4.0% | 2.6%-5.8% | 21 | 6.3% | 4.1%-9.3% | 48 | 6.7% | 5.0%-8.7% |
| Black or African American | 103 | 4.6% | 3.7%-5.5% | 7 | 1.2% | 0.5%-2.4% | 3 | 0.5% | 0.1%-1.4% | 13 | 3.9% | 2.2%-6.5% | 80 | 11.1% | 9.0%-13.5% |
| Asian | 8 | 0.4% | 0.1%-0.7% | 4 | 0.7% | 0.2%-1.7% | 1 | 0.2% | 0.02%-0.9% | 2 | 0.6% | 0.1%-2.1% | 1 | 0.1% | 0.02%-0.7% |
| Other | 1913 | 85.0% | 83.4%-86.4% | 495 | 84.2% | 81.0%-86.9% | 550 | 90.8% | 88.1%-92.8% | 287 | 85.7% | 81.5%-89.0% | 581 | 80.6% | 77.5%-83.3% |
| Multiple | 102 | 4.5% | 3.7%-5.4% | 56 | 9.5% | 7.4%-12.1% | 28 | 4.6% | 3.2%-6.5% | 12 | 3.6% | 2.0%-6.1% | 6 | 0.8% | 0.3%-1.8% |
| Unknown | 5 | 0.2% | 0.1%-0.5% | 0 | 0.0% | 0.0%-0.6% | 0 | 0.0% | 0.0%-0.6% | 0 | 0.0% | 0.0%-1.1% | 5 | 0.7% | 0.2%-1.6% |
| Ethnicity | |||||||||||||||
| Non-Hispanic | 171 | 7.6% | 6.5%-8.7% | 16 | 2.7% | 1.6%-4.3% | 7 | 1.2% | 0.5%-2.3% | 30 | 9.0% | 6.3%-12.45% | 118 | 16.4% | 13.8%-19.2% |
| Hispanic | 2079 | 92.4% | 91.2%-93.4% | 572 | 97.3% | 95.6%-98.3% | 599 | 98.8% | 97.6%-99.4% | 305 | 91.0% | 87.5%-93.6% | 603 | 83.6% | 80.7%-86.1% |
| Preferred language | |||||||||||||||
| English | 236 | 10.5% | 9.2%-11.8% | 39 | 6.6% | 4.8%-8.9% | 9 | 1.5% | 0.7%-2.7% | 29 | 8.7% | 6.0%-12.1% | 159 | 22.1% | 19.1%-25.2% |
| Spanish | 1995 | 88.7% | 87.2%-89.9% | 546 | 92.9% | 90.4%-94.6% | 595 | 98.2% | 96.7%-98.9% | 304 | 90.7% | 87.1%-93.4% | 550 | 76.3% | 73.0%-79.2% |
| Other | 7 | 0.3% | 0.1%-0.6% | 3 | 0.5% | 0.1%-1.4% | 2 | 0.3% | 0.09%-1.1% | 2 | 0.6% | 0.1%-2.1% | 0 | 0.0% | 0.0%-0.5% |
| Unknown | 12 | 0.5% | 0.3%-0.9% | 0 | 0.0% | 0.0%-0.6% | 0 | 0.0% | 0.0%-0.6% | 0 | 0.0% | 0.0%-1.1% | 12 | 1.7% | 0.9%-2.8% |
| Medical history | |||||||||||||||
| Prior COVID-19 | 351 | 23.1% | 20.9%-25.2% | 128 | 21.9% | 18.7%-25.4% | 158 | 26.1% | 22.7%-29.7% | 65 | 19.6% | 15.7%-24.2% | ... | ... | ... |
| Obesity | |||||||||||||||
| BMI >35 | 167 | 19.4% | 16.9%-22.25% | 71 | 18.3% | 14.8%-22.5% | 41 | 17.3% | 13.0%-22.6% | 55 | 23.4% | 18.4%-29.2% | ... | ... | ... |
| BMI >40 | 63 | 7.3% | 5.7%-9.2% | 30 | 7.8% | 5.4%-10.8% | 13 | 5.5% | 3.2%-9.1% | 20 | 8.5% | 5.5%-12.7% | ... | ... | ... |
| Comorbidities | |||||||||||||||
| Cardiovascular disease | 399 | 35.0% | 32.2%-37.8% | 234 | 55.3% | 50.5%-59.9% | 108 | 23.3% | 19.7%-27.3% | 57 | 22.4% | 17.7%-27.9% | ... | ... | ... |
| Diabetes mellitus | 246 | 21.6% | 19.2%-24.0% | 137 | 32.4% | 28.1%-36.9% | 76 | 16.4% | 13.3%-20.0% | 33 | 13.0% | 9.4%-17.6% | ... | ... | ... |
| Chronic pulmonary disease/asthma | 84 | 7.4% | 5.9%-9.0% | 39 | 9.2% | 6.8%-12.3% | 26 | 5.6% | 3.8%-8.1% | 19 | 7.5% | 4.8%-11.3% | ... | ... | ... |
| Cancer within <12 mo | 17 | 1.5% | 0.9%-2.3% | 9 | 2.1% | 1.1%-3.9% | 5 | 1.1% | 0.4%-2.5% | 3 | 1.2% | 0.4%-3.4% | ... | ... | ... |
| Chronic kidney disease | 15 | 1.3% | 0.7%-2.1% | 7 | 1.7% | 0.8%-3.3% | 6 | 1.3% | 0.5%-2.7% | 2 | 0.8% | 0.2%-2.8% | ... | ... | ... |
| Other | 125 | 11.0% | 9.2%-12.9% | 73 | 17.3% | 13.9%-21.1% | 41 | 8.9% | 6.5%-11.7% | 11 | 4.3% | 2.4%-7.5% | ... | ... | ... |
| Occupations | |||||||||||||||
| Construction | 345 | 23.1% | 21.1%-25.3% | 113 | 19.7% | 16.6%-23.1% | 159 | 27.0% | 23.5%-30.7% | 73 | 22.2% | 18.0%-26.9% | ... | ... | ... |
| Janitorial/cleaning | 281 | 18.8% | 16.9%-20.8% | 125 | 21.8% | 18.6%-25.3% | 111 | 18.8% | 15.8%-22.2% | 45 | 13.7% | 10.3%-17.8% | ... | ... | ... |
| Restaurant | 181 | 12.1% | 10.5%-13.8% | 61 | 10.6% | 8.3%-13.4% | 75 | 12.7% | 10.2%-15.6% | 45 | 13.7% | 10.3%-17.8% | ... | ... | ... |
| Manufacturing | 148 | 9.9% | 8.5%-11.5% | 34 | 5.9% | 4.2%-8.1% | 41 | 7.0% | 5.1%-9.3% | 73 | 22.2% | 18.0%-26.9% | ... | ... | ... |
| Grocery | 81 | 5.4% | 4.3%-6.6% | 28 | 4.9% | 3.4%-6.9% | 31 | 5.3% | 3.7%-7.3% | 22 | 6.7% | 4.4%-9.9% | ... | ... | ... |
| Childcare | 62 | 4.2% | 3.2%-5.2% | 39 | 6.8% | 5.0%-9.1% | 11 | 1.9% | 1.0%-3.3% | 12 | 3.6% | 2.0%-6.2% | ... | ... | ... |
| Transportation | 42 | 2.8% | 2.0%-3.7% | 18 | 3.1% | 1.9%-4.9% | 16 | 2.7% | 1.6%-4.3% | 8 | 2.4% | 1.2%-4.7% | ... | ... | ... |
| Painting | 34 | 2.3% | 1.6%-3.1% | 13 | 2.3% | 1.3%-3.8% | 18 | 3.1% | 1.9%-4.7% | 3 | 0.9% | 0.3%-2.6% | ... | ... | ... |
| Health care | 15 | 1.0% | 0.6%-1.6% | 6 | 1.0% | 0.4%-2.2% | 2 | 0.3% | 0.0%-1.2% | 7 | 2.1% | 1.0%-4.3% | ... | ... | ... |
| Education | 10 | 0.7% | 0.3%-1.2% | 2 | 0.3% | 0.0%-1.2% | 1 | 0.2% | 0.0%-0.9% | 7 | 2.1% | 1.0%-4.3% | ... | ... | ... |
| Agriculture | 7 | 0.5% | 0.2%-0.9% | 3 | 0.5% | 0.1%-1.5% | 1 | 0.2% | 0.0%-0.9% | 3 | 0.9% | 0.3%-2.6% | ... | ... | ... |
| Other | 91 | 6.1% | 4.9%-7.4% | 25 | 4.4% | 2.9%-6.3% | 27 | 4.6% | 3.1%-6.5% | 39 | 11.9% | 8.7%-15.7% | ... | ... | ... |
| Unemployed | 269 | 18.0% | 16.1%-20.0% | 133 | 23.2% | 19.9%-26.8% | 113 | 19.2% | 16.2%-22.5% | 23 | 7.0% | 4.7%-10.2% | ... | ... | ... |
| Second-dose completion among patients requiring (Moderna or Pfizer) and due for second dose before May 8, 2021 | |||||||||||||||
| Completed second dose | 884 | 98.7% | 97.6%-99.2% | 473 | 99.4% | 98.1%-99.7% | 189 | 97.9% | 94.7%-99.1% | 126 | 96.9% | 92.3%-98.7% | 96 | 99.0% | 94.3%-99.8% |
| Missing second dose | 12 | 1.3% | 0.7%-2.3% | 3 | 0.6% | 0.2%-1.8% | 4 | 2.1% | 0.8%-5.2% | 4 | 3.1% | 1.2%-7.6% | 1 | 1.0% | 0.1%-5.6% |
Abbreviations: BMI, body mass index; CI, confidence interval.
aData on medical history, obesity comorbidities, and occupation not collected for walk-ups.
b95% Confidence intervals calculated using Wilson score method without continuity correction.
cMedical history total n = 1522 (588 active phone outreach, 606 passive outreach, and 335 street outreach).
dObesity total n= 859 (387 active phone outreach, 237 passive outreach, and 235 street outreach).
eComorbidities total n = 1140 (423 active phone outreach, 463 passive outreach, and 254 street outreach); comorbidities counts are not mutually exclusive.
fOccupations total n = 1491 (573 active phone outreach, 589 passive outreach, and 329 street outreach); occupations counts are not mutually exclusive.
gDose 2 completion (among those requiring and due for second dose) total n = 896 (476 active phone outreach, 193 passive outreach, 130 street outreach, and 97 walk-ups).